PMID: 8600347Feb 1, 1996Paper

Synthesis of a lacI gene analogue with reduced CpG content

Mutation Research
T R SkopekT Pippert

Abstract

A lacI gene analogue with reduced CpG content has been synthesized. Codon usage in the lacI gene was manipulated to remove most CpG sites (82/95; 86%) while maintaining wild-type amino acid sequence. The double-stranded gene sequence was synthesized using standard beta-cyanoethyl phosphoramidite chemistry and subsequently cloned into pBR322. Bacterial promoter sequences with different levels of activity were attached upstream of the modified coding region to study its expression in E. coli. Production of lacI protein was confirmed in a lacI- E. coli strain by Western blot analysis and by measuring repression of the lacZ gene with the chromogenic lacZ indicator, 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal). The modified lacI gene construct can be used as a genetic target in cultured mammalian cells or in transgenic animals to avoid high levels of background mutation associated with methylated CpG sequences. The construction scheme described here provides a general approach to remove CpG sequences from gene constructs when methylation is undesirable.

References

Aug 24, 1978·Nature·P J Farabaugh
Dec 15, 1977·Journal of Molecular Biology·U SchmeissnerJ H Miller
Oct 1, 1991·Genetics·R M Schaaper, R L Dunn
Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S W KohlerJ M Short
Jan 1, 1991·Environmental and Molecular Mutagenesis·S W KohlerJ M Short
Apr 25, 1991·Nucleic Acids Research·K WadaT Ikemura
Apr 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·B Müller-HillW Gilbert
Sep 11, 1984·Nucleic Acids Research·M RobinsonG Humphreys
Apr 11, 1980·Nucleic Acids Research·A P Bird
Nov 7, 1980·Science·A Razin, A D Riggs
Jun 19, 1981·Science·M Ehrlich, R Y Wang
Oct 9, 1980·Nature·B K Duncan, J H Miller
Jun 30, 1982·Biochimica Et Biophysica Acta·R Y WangM Ehrlich
Dec 11, 1982·Nucleic Acids Research·M McClelland, R Ivarie
Jan 1, 1995·Environmental and Molecular Mutagenesis·T R SkopekD R Marino
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·G S Provost, J M Short
Jan 1, 1994·Environmental and Molecular Mutagenesis·S A TaftT R Skopek
Dec 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·W Gilbert, B Müller-Hill

❮ Previous
Next ❯

Citations

Jul 20, 2002·Seminars in Cell & Developmental Biology·Heidi Scrable
Jul 28, 2004·Environmental and Molecular Mutagenesis·Carrie R ValentineRobert R Delongchamp
Oct 17, 1998·Environmental and Molecular Mutagenesis·J A Heddle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.